0001735756-18-000002.txt : 20180516 0001735756-18-000002.hdr.sgml : 20180516 20180516153009 ACCESSION NUMBER: 0001735756-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180516 DATE AS OF CHANGE: 20180516 EFFECTIVENESS DATE: 20180516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eikonizo Therapeutics, Inc. CENTRAL INDEX KEY: 0001735756 IRS NUMBER: 823062283 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312582 FILM NUMBER: 18839881 BUSINESS ADDRESS: STREET 1: 996 HALE STREET CITY: BEVERLY STATE: MA ZIP: 01915 BUSINESS PHONE: 617-308-4405 MAIL ADDRESS: STREET 1: 996 HALE STREET CITY: BEVERLY STATE: MA ZIP: 01915 D 1 primary_doc.xml X0708 D LIVE 0001735756 Eikonizo Therapeutics, Inc. 996 HALE STREET BEVERLY MA MASSACHUSETTS 01915 617-308-4405 DELAWARE None None Corporation true 2017 Janice Kranz 996 Hale Street c/o Eikonizo Therapeutics, Inc. Beverly MA MASSACHUSETTS 01915 Executive Officer Director Stacie Weninger 996 Hale Street c/o Eikonizo Therapeutics, Inc. Beverly MA MASSACHUSETTS 01915 Director William Shaw 996 Hale Street c/o Eikonizo Therapeutics, Inc. Beverly MA MASSACHUSETTS 01915 Executive Officer Director Kevin Kinsella 996 Hale Street c/o Eikonizo Therapeutics, Inc. Beverly MA MASSACHUSETTS 01915 Director Other Health Care Decline to Disclose 06b false 2018-05-15 false true true false 0 841062 371352 469710 false 1 0 0 0 false Eikonizo Therapeutics, Inc. /s/ Janice Kranz Janice Kranz Chief Executive Officer 2018-05-16